Provided by Tiger Trade Technology Pte. Ltd.

Lineage

38.71
+0.96002.54%
Post-market: 38.13-0.5800-1.50%19:32 EDT
Volume:975.94K
Turnover:37.57M
Market Cap:8.79B
PE:-53.76
High:38.77
Open:37.98
Low:37.58
Close:37.75
52wk High:45.75
52wk Low:31.33
Shares:227.08M
Float Shares:57.19M
Volume Ratio:1.10
T/O Rate:1.71%
Dividend:2.12
Dividend Rate:5.48%
EPS(TTM):-0.7200
EPS(LYR):-0.4300
ROE:-2.04%
ROA:0.75%
PB:1.11
PE(LYR):-90.02

Loading ...

Analysts’ Opinions Are Mixed on These NA Stocks: Lineage, Inc. (LINE), Beta Bionics, Inc. (BBNX) and Huron Consulting (HURN)

TIPRANKS
·
Yesterday

Lineage files civil lawsuit against Altus Power, Pearce over June fire

TIPRANKS
·
Sep 11

Lineage, - Files Lawsuit Against Altus Power and Pearce Services over Boyle Heights Fire

THOMSON REUTERS
·
Sep 11

Lineage Sues Altus Power and Pearce Services for Ignoring Safety Warnings and Causing Boyle Heights Fire

GlobeNewswire
·
Sep 11

Lineage Price Target Maintained with a $47.00/Share by Morgan Stanley

Dow Jones
·
Sep 10

Lineage, Inc. : Morgan Stanley Raises to Overweight from Equal Weight

THOMSON REUTERS
·
Sep 09

Morgan Stanley Upgrades Lineage to Overweight From Equalweight

MT Newswires Live
·
Sep 09

Lineage upgraded to Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Sep 09

Lineage chairman buys $987.6K in common stock

TIPRANKS
·
Sep 02

Lineage Co-Executive Chairman Kevin Patrick Marchetti Acquires USD 987,555 of Common Shares

Reuters
·
Sep 02

Lineage is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 01

Lineage Price Target Cut to $44.00/Share from $46.00 by Piper Sandler

Dow Jones
·
Aug 28

Morgan Stanley Sticks to Their Hold Rating for Lineage, Inc. (LINE)

TIPRANKS
·
Aug 25

Lineage Cell Therapeutics management to meet with B. Riley

TIPRANKS
·
Aug 25

Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)

TIPRANKS
·
Aug 20

KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering

GlobeNewswire
·
Aug 18

Lineage Seen Benefiting From Improving Industry Conditions, RBC Capital Markets Says

MT Newswires Live
·
Aug 17

RBC Raises Price Target on Lineage to $48 From $44, Keeps Outperform Rating

MT Newswires Live
·
Aug 17

Lineage, Inc. : RBC Raises Target Price to $48 from $44

THOMSON REUTERS
·
Aug 17

Should Widening Losses Despite Higher Sales in Q2 2026 Require Action From Lineage (LINE) Investors?

Simply Wall St.
·
Aug 16